Population-based study of the association of variants in mismatch repair genes with prostate cancer risk and outcomes

Cancer Epidemiology Biomarkers and Prevention

Volumn 19, Issue 1, 2010, Pages 258-264

  Langeberg, Wendy J ^a,b   Kwon, Erika M ^c   Koopmeiners, Joseph S ^a,b   Ostrander, Elaine A ^c   Stanford, Janet L ^a,b  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN;

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; CANCER MORTALITY; CANCER RECURRENCE; CANCER REGISTRY; CANCER RISK; CASE CONTROL STUDY; CAUCASIAN; COMPARATIVE STUDY; CONTROLLED STUDY; GENE; GENETIC VARIABILITY; HAPLOTYPE; HAZARD RATIO; HUMAN; HUMAN TISSUE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MISMATCH REPAIR; MLH1 GENE; MSH2 GENE; OUTCOME ASSESSMENT; PMS2 GENE; POPULATION RESEARCH; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROSTATE CANCER; SINGLE NUCLEOTIDE POLYMORPHISM; UNITED STATES;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADENOSINE TRIPHOSPHATASES; ADULT; AGED; CASE-CONTROL STUDIES; DNA MISMATCH REPAIR; DNA REPAIR ENZYMES; DNA-BINDING PROTEINS; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MUTS HOMOLOG 2 PROTEIN; NEOPLASM RECURRENCE, LOCAL; NUCLEAR PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSTATIC NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 74549203193     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-09-0800     Document Type: Article

References (33)

1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin 2008;58:71-96.
2. Salinas CA, Koopmeiners JS, Kwon EM, et al. Clinical utility of five genetic variants for predicting prostate cancer risk and mortality. Prostate 2009;69:363-72.
3. Lynch HT, de la Chapelle A. Hereditary Colorectal Cancer. N Engl J Med 2003;348:919-32.
4. Colombo P, Patriarca C, Alfano RM, et al. Molecular disorders in transitional vs. peripheral zone prostate adenocarcinoma. Int J Cancer 2001;94:383-9.
5. Dahiya R, Lee C, McCarville J, Hu W, Kaur G, Deng G. High frequency of genetic instability of microsatellites in human prostatic adenocarcinoma. Int J Cancer 1997;72:762-7.
6. Egawa S, Uchida T, Suyama K, et al. Genomic instability of microsatellite repeats in prostate cancer: relationship to clinicopathological variables. Cancer Res 1995;55:2418-21.
7. Uchida T, Wada C, Wang C, et al. Microsatellite instability in prostate cancer. Oncogene 1995;10:1019-22.
8. Gao X, Wu N, Grignon D, et al. High frequency of mutator phenotype in human prostatic adenocarcinoma. Oncogene 1994;9:2999-3003.
9. Suzuki H, Komiya A, Aida S, et al. Microsatellite instability and other molecular abnormalities in human prostate cancer. Jpn J Cancer Res 1995;86:956-61.
10. Cunningham JM, Shan A, Wick MJ, et al. Allelic imbalance and microsatellite instability in prostatic adenocarcinoma. Cancer Res 1996;56:4475-82.
11. Zhou XP, Hoang JM, Li YJ, et al. Determination of the replication error phenotype in human tumors without the requirement for matching normal DNA by analysis of mononucleotide repeat microsatellites. Genes Chromosomes Cancer 1998;21:101-7.
12. Ahman AK, Jonsson BA, Damber JE, Bergh A, Grönberg H. Low frequency of microsatellite instability in hereditary prostate cancer. BJU Int 2001;87:334-8.
13. Terrell RB, Wille AH, Cheville JC, Nystuen AM, Cohen MB, Sheffield VC. Microsatellite instability in adenocarcinoma of the prostate. Am J Pathol 1995;147:799-805.
14. Rohrbach H, Haas CJ, Baretton GB, et al. Microsatellite instability and loss of heterozygosity in prostatic carcinomas: comparison of primary tumors, and of corresponding recurrences after androgen deprivation therapy and lymph-node metastases. Prostate 1999; 40:20-7.
15. Boyer JC, Umar A, Risinger JI, et al. Microsatellite instability mismatch repair deficiency, and genetic defects in human cancer cell lines. Cancer Res 1995;55:6063-70.
16. Leach FS, Velasco A, Hsieh JT, Sagalowsky AI, McConnell JD. The mismatch repair gene hMSH2 is mutated in the prostate cancer cell line LNCaP. J Urol 2000;164:1830-3.
17. Yeh CC, Lee C, Dahiya R. DNA mismatch repair enzyme activity and gene expression in prostate cancer. Biochem Biophys Res Commun 2001;285:409-13.
18. Chen Y, Wang J, Fraig MM, et al. Defects of DNA mismatch repair in human prostate cancer. Cancer Res 2001;61:4112-21.
19. Chen Y, Wang J, Fraig MM, et al. Alterations in PMS2, MSH2 and MLH1 expression in human prostate cancer. Int J Oncol 2003;22: 1033-43.
20. Norris AM, Woodruff RD, D'Agostino RB, Jr., Clodfelter JE, Scarpinato KD. Elevated levels of the mismatch REPAIR protein PMS2 are associated with prostate cancer. Prostate 2007;67:214-25.
21. Prtilo A, Leach FS, Markwalder R, et al. Tissue microarray analysis of hMSH2 expression predicts outcome in men with prostate cancer. J Urol 2005;174:1814-8.
22. VelascoA,AlbertPS,RosenbergH,MartinezC, LeachFS.Clinicopathologic implications of hMSH2 gene expression and microsatellite instability in prostate cancer. Cancer Biol Ther 2002;1:362-7.
23. Velasco A, Hewitt SM, Albert PS, et al. Differential expression of the mismatch repair gene hMSH2 in malignant prostate tissue is associated with cancer recurrence. Cancer 2002;94:690-9.
24. Norris AM, Gentry M, Peehl DM, D'Agostino R, Jr., Scarpinato KD. The elevated expression of a mismatch repair protein is a predictor for biochemical recurrence after radical prostatectomy. Cancer Epidemiol Biomarkers Prev 2009;18:57-64.
25. Burmester JK, Suarez BK, Lin JH, et al. Analysis of candidate genes for prostate cancer. Hum Hered 2004;57:172-8.
26. Fredriksson H, Ikonen T, Autio V, et al. Identification of germline MLH1 alterations in familial prostate cancer. Eur J Cancer 2006;42: 2802-6.
27. Stanford JL, Wicklund KG, McKnight B, Daling JR, Brawer MK. Vasectomy and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 1999;8:881-6.
28. Agalliu I, Salinas CA, Hansten PD, Ostrander EA, Stanford JL. Statin use and risk of prostate cancer: results from a population-based epidemiological study. Am J Epidemiol 2008;168:250-60.
29. Fitzgerald LM, Kwon EM, Koopmeiners JS, Salinas CA, Stanford JL, Ostrander EA. Analysis of recently identified prostate cancer susceptibility loci in a population-based study: associations with family history and clinical features. Clin Cancer Res 2009;15:3231-7.
30. Smith TR, Levine EA, Freimanis RI, et al. Polygenic model of DNA repair genetic polymorphisms in human breast cancer risk. Carcino-genesis 2008;29:2132-8.
31. Mathonnet G, Krajinovic M, Labuda D, Sinnett D. Role of DNA mismatch repair genetic polymorphisms in the risk of childhood acute lymphoblastic leukaemia. Br J Haematol 2003;123:45-8.
32. Amundadottir LT, Sulem P, Gudmundsson J, et al. A common variant associated with prostate cancer in European and African populations. Nat Genet 2006;38:652-8.
33. Haiman CA, Le Marchand L, Yamamato J, et al. A common genetic risk factor for colorectal and prostate cancer. Nat Genet 2007;39: 954-6.